Dawn E. Quelle
Affiliations: | Molecular and Cell Biology | University of Iowa, Iowa City, IA |
Area:
Molecular Biology, Cell BiologyGoogle:
"Dawn Quelle"Children
Sign in to add trainee| Chandrashekhar K. Korgaonkar | grad student | 2003 | University of Iowa |
| Van S. Tompkins | grad student | 2007 | University of Iowa |
| Viviane P. Muniz | grad student | 2012 | University of Iowa |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tow DH, Tran CG, Borbon LC, et al. (2023) Inhibition of serotonin biosynthesis in neuroendocrine neoplasm suppresses tumor growth . Biorxiv : the Preprint Server For Biology |
| Kohlmeyer JL, Kaemmer CA, Lingo JJ, et al. (2022) Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo. Neuro-Oncology Advances. 4: vdac047 |
| Maharjan CK, Umesalma S, Kaemmer CA, et al. (2021) RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo. Biomedicines. 9 |
| Kohlmeyer JL, Kaemmer CA, Umesalma S, et al. (2021) RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner. International Journal of Molecular Sciences. 22 |
| Kaemmer CA, Umesalma S, Maharjan CK, et al. (2021) Development and comparison of novel bioluminescent mouse models of pancreatic neuroendocrine neoplasm metastasis. Scientific Reports. 11: 10252 |
| Desai C, Thomason J, Kohlmeyer JL, et al. (2021) Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas. Oncotarget. 12: 740-755 |
| Kohlmeyer JL, Gordon DJ, Tanas MR, et al. (2021) Combination therapies for MPNSTs targeting RABL6A-RB1 signaling. Oncotarget. 12: 10-14 |
| Kohlmeyer JL, Gordon DJ, Tanas MR, et al. (2020) CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets. International Journal of Molecular Sciences. 21 |
| Kohlmeyer JL, Kaemmer CA, Pulliam C, et al. (2020) RABL6A is an essential driver of MPNSTs that negatively regulates the RB1 pathway and sensitizes tumor cells to CDK4/6 inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Scott AT, Weitz M, Breheny PJ, et al. (2020) Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |